176 related articles for article (PubMed ID: 25988671)
1. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment.
Chou ML; Lin LT; Devos D; Burnouf T
Transfusion; 2015 Oct; 55(10):2433-44. PubMed ID: 25988671
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.
Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS
J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798
[TBL] [Abstract][Full Text] [Related]
3. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
5. Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay.
Hellum M; Øvstebø R; Trøseid AM; Berg JP; Brandtzaeg P; Henriksson CE
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):520-6. PubMed ID: 22732249
[TBL] [Abstract][Full Text] [Related]
6. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
7. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived microparticles trigger THP-1 monocytic cell aggregation and release of pro-coagulant tissue factor-expressing microparticles in vitro.
Lin HC; Chang HW; Hsiao SH; Chou ML; Seghatchian J; Burnouf T
Transfus Apher Sci; 2015 Oct; 53(2):246-52. PubMed ID: 26597313
[TBL] [Abstract][Full Text] [Related]
9. Pre-analytical and analytical issues in the analysis of blood microparticles.
Yuana Y; Bertina RM; Osanto S
Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
[TBL] [Abstract][Full Text] [Related]
10. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.
Boknäs N; Faxälv L; Lindahl TL; Ramström S
J Thromb Haemost; 2014 Apr; 12(4):515-8. PubMed ID: 24405583
[TBL] [Abstract][Full Text] [Related]
11. [Coagulation properties of erythrocyte derived membrane microparticles].
Antonova OA; Shustova ON; Golubeva NV; Yakushkin VV; Alchinova IB; Karganov MY; Mazurov AV
Biomed Khim; 2019 Apr; 65(3):214-221. PubMed ID: 31258144
[TBL] [Abstract][Full Text] [Related]
12. Procoagulant role of microparticles in routine storage of packed red blood cells: potential risk for prothrombotic post-transfusion complications.
Aung HH; Tung JP; Dean MM; Flower RL; Pecheniuk NM
Pathology; 2017 Jan; 49(1):62-69. PubMed ID: 27899173
[TBL] [Abstract][Full Text] [Related]
13. Microparticle-associated tissue factor activity correlates with plasma levels of bacterial lipopolysaccharides in meningococcal septic shock.
Hellum M; Øvstebø R; Brusletto BS; Berg JP; Brandtzaeg P; Henriksson CE
Thromb Res; 2014 Mar; 133(3):507-14. PubMed ID: 24423888
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
Marchetti M; Tartari CJ; Russo L; Panova-Noeva M; Leuzzi A; Rambaldi A; Finazzi G; Woodhams B; Falanga A
Am J Hematol; 2014 Jan; 89(1):68-73. PubMed ID: 24009132
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation.
Rubin O; Delobel J; Prudent M; Lion N; Kohl K; Tucker EI; Tissot JD; Angelillo-Scherrer A
Transfusion; 2013 Aug; 53(8):1744-54. PubMed ID: 23228139
[TBL] [Abstract][Full Text] [Related]
16. A simple clot based assay for detection of procoagulant cell-derived microparticles.
Patil R; Ghosh K; Shetty S
Clin Chem Lab Med; 2016 May; 54(5):799-803. PubMed ID: 26516932
[TBL] [Abstract][Full Text] [Related]
17. Circulating microparticles in carriers of prothrombin G20210A mutation.
Campello E; Spiezia L; Radu CM; Gavasso S; Zerbinati P; Woodhams B; Simioni P
Thromb Haemost; 2014 Sep; 112(3):432-7. PubMed ID: 24816676
[TBL] [Abstract][Full Text] [Related]
18. Impact of Epicatechin on the Procoagulant Activities of Microparticles.
Sinegre T; Milenkovic D; Bourgne C; Teissandier D; Nasri Y; Dannus LT; Morand C; Lebreton A
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992756
[TBL] [Abstract][Full Text] [Related]
19. Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women.
Radu CM; Campello E; Spiezia L; Dhima S; Visentin S; Gavasso S; Woodhams B; Cosmi E; Simioni P
Scand J Clin Lab Invest; 2015 Oct; 75(6):487-95. PubMed ID: 26067611
[TBL] [Abstract][Full Text] [Related]
20. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT.
Connor DE; Exner T; Ma DD; Joseph JE
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):558-64. PubMed ID: 19593114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
